YU13202A - Sferni aglomerati telitromicina, postupak za njihovo dobijanje i njihova primena u dobijanju farmaceutskih oblika - Google Patents

Sferni aglomerati telitromicina, postupak za njihovo dobijanje i njihova primena u dobijanju farmaceutskih oblika

Info

Publication number
YU13202A
YU13202A YU13202A YUP13202A YU13202A YU 13202 A YU13202 A YU 13202A YU 13202 A YU13202 A YU 13202A YU P13202 A YUP13202 A YU P13202A YU 13202 A YU13202 A YU 13202A
Authority
YU
Yugoslavia
Prior art keywords
preparation
production
pharmaceutical forms
spherical
clusters
Prior art date
Application number
YU13202A
Other languages
English (en)
Inventor
Jean-Yves Godard
Valerie Rognon
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU13202(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of YU13202A publication Critical patent/YU13202A/sh
Publication of RS50433B publication Critical patent/RS50433B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Pronalazak ima za objekat sferne aglomerate telitromicina. Pronalazak ima takodje za objekat postupak dobijanja sfernih aglomerata telitromicina, okarakterisan time što se priprema suspenzija kristala faze koja je nerastvorna u telitromicinu koja kristališe brzo. Sferni aglomerati pronalaska nalaze svoju primenu u pripremanju mikrokapsula.
YUP-132/02A 1999-08-26 2000-08-28 Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika RS50433B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (2)

Publication Number Publication Date
YU13202A true YU13202A (sh) 2004-09-03
RS50433B RS50433B (sr) 2009-12-31

Family

ID=9549351

Country Status (34)

Country Link
US (1) US6825218B1 (sh)
EP (1) EP1212336B1 (sh)
JP (1) JP4871467B2 (sh)
KR (1) KR100718222B1 (sh)
CN (1) CN1183151C (sh)
AR (1) AR025398A1 (sh)
AT (1) ATE255590T1 (sh)
AU (1) AU774385B2 (sh)
BR (1) BR0013569B1 (sh)
CA (1) CA2382497C (sh)
CO (1) CO5190666A1 (sh)
CZ (1) CZ2002594A3 (sh)
DE (1) DE60006976T2 (sh)
DK (1) DK1212336T3 (sh)
EA (1) EA005080B1 (sh)
ES (1) ES2209970T3 (sh)
FR (1) FR2797875B1 (sh)
HK (1) HK1049167B (sh)
HR (1) HRP20020167B1 (sh)
HU (1) HU229075B1 (sh)
IL (2) IL148128A0 (sh)
ME (2) MEP20108A (sh)
MX (1) MXPA02001988A (sh)
NO (1) NO322622B1 (sh)
PL (1) PL204100B1 (sh)
PT (1) PT1212336E (sh)
RS (1) RS50433B (sh)
SI (1) SI1212336T1 (sh)
SK (1) SK287588B6 (sh)
TR (1) TR200200506T2 (sh)
TW (1) TWI272949B (sh)
UA (1) UA73523C2 (sh)
WO (1) WO2001014393A2 (sh)
ZA (1) ZA200201599B (sh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
EP1524966B1 (en) * 2002-07-19 2009-11-25 Aventis Pharma S.A. Taste masked oral composition of telithromycin
DK1610878T3 (da) * 2003-02-21 2014-12-01 Univ Bath Fremgangsmåde til fremstilling af partikler
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (en) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
ES2209970T3 (es) 2004-07-01
EP1212336B1 (fr) 2003-12-03
BR0013569A (pt) 2002-05-14
FR2797875B1 (fr) 2001-10-19
TWI272949B (en) 2007-02-11
PL353137A1 (en) 2003-10-20
TR200200506T2 (tr) 2002-08-21
HK1049167B (zh) 2005-08-19
NO322622B1 (no) 2006-11-06
ZA200201599B (en) 2003-04-30
AU7018100A (en) 2001-03-19
HUP0202842A3 (en) 2003-03-28
UA73523C2 (uk) 2005-08-15
HU229075B1 (hu) 2013-07-29
JP4871467B2 (ja) 2012-02-08
WO2001014393A3 (fr) 2001-06-21
NO20020926D0 (no) 2002-02-26
PL204100B1 (pl) 2009-12-31
MEP20108A (en) 2010-06-10
AR025398A1 (es) 2002-11-27
CA2382497A1 (fr) 2001-03-01
AU774385B2 (en) 2004-06-24
CN1183151C (zh) 2005-01-05
HK1049167A1 (en) 2003-05-02
CZ2002594A3 (cs) 2002-09-11
MXPA02001988A (es) 2002-08-20
US6825218B1 (en) 2004-11-30
EP1212336A2 (fr) 2002-06-12
FR2797875A1 (fr) 2001-03-02
RS50433B (sr) 2009-12-31
IL148128A (en) 2006-10-31
KR100718222B1 (ko) 2007-05-15
CN1371386A (zh) 2002-09-25
SI1212336T1 (en) 2004-04-30
BR0013569B1 (pt) 2014-02-25
PT1212336E (pt) 2004-04-30
HRP20020167B1 (en) 2006-06-30
KR20020033771A (ko) 2002-05-07
EA200200294A1 (ru) 2002-08-29
SK2532002A3 (en) 2002-09-10
HUP0202842A2 (hu) 2003-01-28
JP2003507484A (ja) 2003-02-25
HRP20020167A2 (en) 2003-06-30
DK1212336T3 (da) 2004-03-15
ME00112B (me) 2010-10-10
NO20020926L (no) 2002-02-26
IL148128A0 (en) 2002-09-12
WO2001014393A2 (fr) 2001-03-01
CO5190666A1 (es) 2002-08-29
DE60006976D1 (de) 2004-01-15
EA005080B1 (ru) 2004-10-28
SK287588B6 (sk) 2011-03-04
CA2382497C (fr) 2011-06-28
ATE255590T1 (de) 2003-12-15
DE60006976T2 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
YU13202A (sh) Sferni aglomerati telitromicina, postupak za njihovo dobijanje i njihova primena u dobijanju farmaceutskih oblika
DK0991653T3 (da) Nye forbindelser
NO20001670L (no) Fremgangsmate for fremstilling av en smaksmaskert farmasoytisk blanding og smaksmaskert farmasoytisk blanding fremstilt ifolge denne fremgangsmaten, samt smaksmaskerte tyggbare tabletter
DK1343480T3 (da) Induceret faseovergangsmetode til fremstilling af mikropartikler indeholdende hydrofobe aktive midler
ES488888A1 (es) Procedimiento de fabricacion de una suspension acuosa de alumina
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
ZA200409862B (en) Benzofused heteroaryl derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
EP1832298A4 (en) MATRIX-TYPE-CONTROLLED RELEASE PREPARATION COMPRISING A BASIC SUBSTANCE OR SALT THEREOF AND PROCESS FOR PRODUCTION THEREOF
FR2811318B1 (fr) Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
TWI317736B (en) Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications
WO2003077842A3 (en) Palatable oral suspension and method
HUP0402391A3 (en) Crystalline sodium salt of telmisartan, process for its production and pharmaceutical compositions containing it
IL157890A0 (en) P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same
HUP9901616A3 (en) Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same
TR199900548A3 (tr) Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi.
NO20005838L (no) Farmasöytisk multipartikkelform med programmert og styrt frigivning, samt fremstilling derav
PT1223972E (pt) Suspensao de uma proteina de epi-hne processo para a sua preparacao aerossol de po anidro derivado dela composicoes farmaceuticas contendo a referida suspensao ou aerossol e as suas utilizacoes
NO983860L (no) Nye triazolopuriner, fremgangsmÕte for deres fremstilling og deres anvendelse som legemidler
ME00568A (en) Ciclesonide-containing aqueous pharmaceutical composition
DK1077762T3 (da) Fremgangsmåde til fremstilling af sfæriske oxidpartikler
HUP0100398A2 (hu) Eljárás gyógyászati készítmény előállítására
HUP0100957A3 (en) 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same, their use and pharmaceutical compositions containing them
IS3947A (is) Amínósýru afleiður, aðferð til framleiðslu þeirraog notkunar sem lyfja
FR2812884B1 (fr) Levures modifiees et utilisations, notamment pour la production de derives steroidiens